Neural stem cell-mediated therapy for rare brain diseases: Perspectives in the near future for LSDs and MNDs

Histology and Histopathology

Volumn 26, Issue 8, 2011, Pages 1093-1109

  de Filippis, Lidia ^a  

^a UNIVERSITY OF MILANO BICOCCA   (Italy)

Author keywords

Amyotrophic lateral sclerosis; Clinical trials; Lysosomal storage diseases; Motor neuron diseases; Neural stem cells

Indexed keywords

AMYOTROPHIC LATERAL SCLEROSIS; HUMAN; LYSOSOME STORAGE DISEASE; NEURAL STEM CELL; PATHOLOGY; REVIEW; STEM CELL TRANSPLANTATION; TRANSPLANTATION;

AMYOTROPHIC LATERAL SCLEROSIS; HUMANS; LYSOSOMAL STORAGE DISEASES; NEURAL STEM CELLS; STEM CELL TRANSPLANTATION;

EID: 80053202206     PISSN: 02133911     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (153)

1. Aboody K.S., Najbauer J. and Danks M.K. (2008). Stem and progenitor cell-mediated tumor selective gene therapy. Gene Ther. 15, 739-752.
2. Acsadi G., Anguelov R.A., Yang H., Toth G., Thomas R., Jani A., Wang Y., Ianakova E., Mohammad S., Lewis R.A. and Shy M.E. (2002). Increased survival and function of sod1 mice after glial cell-derived neurotrophic factor gene therapy. Hum. Gene Ther. 13, 1047-1059.
3. Aleckovic M. and Simon C. (2008). Is teratoma formation in stem cell research a characterization tool or a window to developmental biology? Reprod. Biomed. Online 17, 270-280.
4. Alexianu M.E., Kozovska M. and Appel S.H. (2001). Immune reactivity in a mouse model of familial als correlates with disease progression. Neurology 57, 1282-1289.
5. Alper J. (2009). Geron gets green light for human trial of es cell-derived product. Nat. Biotechnol. 27, 213-214.
6. Andrus P.K., Fleck T.J., Gurney M.E. and Hall E.D. (1998). Protein oxidative damage in a transgenic mouse model of familial amyotrophic lateral sclerosis. J. Neurochem. 71, 2041-2048.
7. Azzouz M., Ralph G.S., Storkebaum E., Walmsley L.E., Mitrophanous K.A., Kingsman S. M., Carmeliet P. and Mazarakis N. D. (2004). Vegf delivery with retrogradely transported lentivector prolongs survival in a mouse als model. Nature 429, 413-417.
8. Bacigaluppi M., Pluchino S., Peruzzotti Jametti L., Kilic E., Kilic U., Salani G., Brambilla E., West M.J., Comi G., Martino G. and Hermann D.M. (2009). Delayed post-ischaemic neuroprotection following systemic neural stem cell transplantation involves multiple mechanisms. Brain 132, 2239-2251.
9. Barbeito L.H., Pehar M., Cassina P., Vargas M.R., Peluffo H., Viera L., Estevez A.G. and Beckman J.S. (2004). A role for astrocytes in motor neuron loss in amyotrophic lateral sclerosis. Brain Res. Brain Res. Rev. 47, 263-274.
10. Belsh J.M. and Schiffman P.L. (1990). Misdiagnosis in patients with amyotrophic lateral sclerosis. Arch. Intern. Med. 150, 2301-2305.
11. Bjorklund A., Dunnett S.B., Brundin P., Stoessl A.J., Freed C.R., Breeze R.E., Levivier M., Peschanski M., Studer L. and Barker R. (2003). Neural transplantation for the treatment of Parkinson's disease. Lancet Neurol. 2, 437-445.
12. Bottai D., Fiocco R., Gelain F., De Filippis L., Galli R., Gritti A. and Vescovi L.A. (2003). Neural stem cells in the adult nervous system. J. Hematother. Stem Cell Res. 12, 655-670.
13. Bruijn L.I., Miller T.M. and Cleveland D.W. (2004). Unraveling the mechanisms involved in motor neuron degeneration in ALS. Annu. Rev. Neurosci. 27, 723-749.
14. Cardone M., Polito V.A., Pepe S., Mann L., D'Azzo A., Auricchio A., Ballabio A. and Cosma M.P. (2006). Correction of hunter syndrome in the mpsii mouse model by aav2/8-mediated gene delivery. Hum. Mol. Genet. 15, 1225-1236.
15. Cashman N., Tan L.Y., Krieger C., Madler B., Mackay A., Mackenzie I., Benny B., Nantel S., Fabros M., Shinobu L., Yousefi M. and Eisen A. (2008). Pilot study of granulocyte colony stimulating factor (g-csf)-mobilized peripheral blood stem cells in amyotrophic lateral sclerosis (als). Muscle Nerve 37, 620-625.
16. Casoni F., Basso M., Massignan T., Gianazza E., Cheroni C., Salmona M., Bendotti C. and Bonetto V. (2005). Protein nitration in a mouse model of familial amyotrophic lateral sclerosis: Possible multifunctional role in the pathogenesis. J. Biol. Chem. 280, 16295-16304.
17. Chen R. and Ende N. (2000). The potential for the use of mononuclear cells from human umbilical cord blood in the treatment of amyotrophic lateral sclerosis in sod1 mice. J. Med. 31, 21-30.
18. Consiglio A., Gritti A., Dolcetta D., Follenzi A., Bordignon C., Gage F.H., Vescovi A.L. and Naldini L. (2004). Robust in vivo gene transfer into adult mammalian neural stem cells by lentiviral vectors. Proc. Natl. Acad. Sci. USA 101, 14835-14840.
19. Corti S., Locatelli F., Papadimitriou D., Del Bo R., Nizzardo M., Nardini M., Donadoni C., Salani S., Fortunato F., Strazzer S., Bresolin N. and Comi G.P. (2007). Neural stem cells lewisx+ cxcr4+ modify disease progression in an amyotrophic lateral sclerosis model. Brain 130, 1289-1305.
20. Corti S., Locatelli F., Papadimitriou D., Donadoni C., Del Bo R., Crimi M., Bordoni A., Fortunato F., Strazzer S., Menozzi G., Salani S., Bresolin N. and Comi G.P. (2006). Transplanted aldhhissclo neural stem cells generate motor neurons and delay disease progression of nmd mice, an animal model of smard1. Hum. Mol. Genet. 15, 167-187.
21. Craig C.G., Tropepe V., Morshead C.M., Reynolds B.A., Weiss S. and van der Kooy D. (1996). In vivo growth factor expansion of endogenous subependymal neural precursor cell populations in the adult mouse brain. J. Neurosci. 16, 2649-2658.
22. Dasen J.S., Liu J.P. and Jessell T.M. (2003). Motor neuron columnar fate imposed by sequential phases of hox-c activity. Nature 425, 926-933.
23. Dasen J.S., Tice B.C., Brenner-Morton S. and Jessell T.M. (2005). A hox regulatory network establishes motor neuron pool identity and target-muscle connectivity. Cell 123, 477-491.
24. De Filippis L., Lamorte G., Snyder E.Y., Malgaroli A. and Vescovi A.L. (2007). A novel, immortal, and multipotent human neural stem cell line generating functional neurons and oligodendrocytes. Stem cells (Dayton, Ohio) 25, 2312-2321.
25. De Filippis L., Ferrari D., Rota Nodari L., Amati B., Snyder E. and Vescovi A.L. (2008). Immortalization of human neural stem cells with the c-myc mutant T58A. PloS one 3, e3310.
26. Dietrich-Neto F., Callegaro D., Dias-Tosta E., Silva H.A., Ferraz M.E., Lima J.M. and Oliveira A.S. (2000). Amyotrophic lateral sclerosis in brazil: 1998 national survey. Arq. Neuropsiquiatr. 58, 607-615.
27. Dimos J.T., Rodolfa K.T., Niakan K.K., Weisenthal L.M., Mitsumoto H., Chung W., Croft G.F., Saphier G., Leibel R., Goland R., Wichterle H., Henderson C.E. and Eggan K. (2008). Induced pluripotent stem cells generated from patients with als can be differentiated into motor neurons. Science 321, 1218-1221.
28. Ebert A.D., Beres A.J., Barber A.E. and Svendsen C.N. (2008). Human neural progenitor cells over-expressing igf-1 protect dopamine neurons and restore function in a rat model of parkinson's disease. Exp. Neurol. 209, 213-223.
29. Ebert A.D., Barber A.E., Heins B.M. and Svendsen C.N. (2010). Ex vivo delivery of gdnf maintains motor function and prevents neuronal loss in a transgenic mouse model of huntington's disease. Exp. Neurol. 224, 155-162.
30. Elstein D. (2011). Recent advances in treatment approaches to gaucher disease. Curr. Pharm. Biotechnol.
31. Ende N., Weinstein F., Chen R. and Ende M. (2000). Human umbilical cord blood effect on sod mice (amyotrophic lateral sclerosis). Life Sci. 67, 53-59.
32. Eng C.M., Guffon N., Wilcox W.R., Germain D.P., Lee P., Waldek S., Caplan L., Linthorst G.E. and Desnick R.J. (2001). Safety and efficacy of recombinant human alpha-galactosidase a-replacement therapy in fabry's disease. N. Engl. J. Med. 345, 9-16.
33. Flax J.D., Aurora S., Yang C., Simonin C., Wills A.M., Billinghurst L.L., Jendoubi M., Sidman R.L., Wolfe J.H., Kim S.U. and Snyder E.Y. (1998). Engraftable human neural stem cells respond to developmental cues, replace neurons, and express foreign genes. Nat. biotechnol. 16, 1033-1039.
34. Foroni C., Galli R., Cipelletti B., Caumo A., Alberti S., Fiocco R. and Vescovi A. (2007). Resilience to transformation and inherent genetic and functional stability of adult neural stem cells ex vivo. Cancer Res. 67, 3725-3733.
35. Fraldi A., Hemsley K., Crawley A., Lombardi A., Lau A., Sutherland L., Auricchio A., Ballabio A. and Hopwood J.J. (2007). Functional correction of cns lesions in an mps-iiia mouse model by intracerebral aav-mediated delivery of sulfamidase and sumf1 genes. Human Mol. Genet. 16, 2693-2702.
36. Friso A., Tomanin R., Alba S., Gasparotto N., Puicher E.P., Fusco M., Hortelano G., Muenzer J., Marin O., Zacchello F. and Scarpa M. (2005). Reduction of gag storage in mps ii mouse model following implantation of encapsulated recombinant myoblasts. J. Gene Med. 7, 1482-1491.
37. Fukuhara Y., Li X.K., Kitazawa Y., Inagaki M., Matsuoka K., Kosuga M., Kosaki R., Shimazaki T., Endo H., Umezawa A., Okano H., Takahashi T. and Okuyama T. (2006). Histopathological and behavioral improvement of murine mucopolysaccharidosis type vii by intracerebral transplantation of neural stem cells. Mol. Ther. 13, 548-555.
38. Galli R., Binda E., Orfanelli U., Cipelletti B., Gritti A., De Vitis S., Fiocco R., Foroni C., Dimeco F. and Vescovi A. (2004). Isolation and characterization of tumorigenic, stem-like neural precursors from human glioblastoma. Cancer Res. 64, 7011-7021.
39. Gao J., Coggeshall R.E., Tarasenko Y.I. and Wu P. (2005). Human neural stem cell-derived cholinergic neurons innervate muscle in motoneuron deficient adult rats. Neuroscience 131, 257-262.
40. Garcia A.R., Pan J., Lamsa J.C. and Muenzer J. (2007). The characterization of a murine model of mucopolysaccharidosis ii (hunter syndrome). J. Inherit. Metab. Dis. 30, 924-934.
41. Gieselmann V. and Krageloh-Mann I. (2010). Metachromatic leukodystrophy--an update. Neuropediatrics 41, 1-6.
42. Givogri M.I., Bottai D., Zhu H.L., Fasano S., Lamorte G., Brambilla R., Vescovi A., Wrabetz L. and Bongarzone E. (2008). Multipotential neural precursors transplanted into the metachromatic leukodystrophy brain fail to generate oligodendrocytes but contribute to limit brain dysfunction. Dev. Neurosci. 30, 340-357.
43. Givogri M.I., Galbiati F., Fasano S., Amadio S., Perani L., Superchi D., Morana P., Del Carro U., Marchesini S., Brambilla R., Wrabetz L. and Bongarzone E. (2006). Oligodendroglial progenitor cell therapy limits central neurological deficits in mice with metachromatic leukodystrophy. J. Neurosci. 26, 3109-3119.
44. Glass C.K., Saijo K., Winner B., Marchetto M.C. and Gage F.H. (2010). Mechanisms underlying inflammation in neurodegeneration. Cell 140, 918-934.
45. Gonzalez-Perez O., Romero-Rodriguez R., Soriano-Navarro M., Garcia-Verdugo J.M. and Alvarez-Buylla A. (2009). Epidermal growth factor induces the progeny of subventricular zone type b cells to migrate and differentiate into oligodendrocytes. Stem cells (Dayton, Ohio) 27, 2032-2043.
46. Gordon P.H., Cheng B., Katz I.B., Pinto M., Hays A.P., Mitsumoto H. and Rowland L.P. (2006). The natural history of primary lateral sclerosis. Neurology 66, 647-653.
47. Graber D.J., Hickey W.F. and Harris B.T. (2010). Progressive changes in microglia and macrophages in spinal cord and peripheral nerve in the transgenic rat model of amyotrophic lateral sclerosis. J. Neuroinflammation 7, 8.
48. Gritti A., Cova L., Parati E.A., Galli R. and Vescovi A.L. (1995). Basic fibroblast growth factor supports the proliferation of epidermal growth factor-generated neuronal precursor cells of the adult mouse cns. Neurosci. Lett. 185, 151-154.
49. Gritti A., Frolichsthal-Schoeller P., Galli R., Parati E.A., Cova L., Pagano S.F., Bjornson C.R. and Vescovi A.L. (1999). Epidermal and fibroblast growth factors behave as mitogenic regulators for a single multipotent stem cell-like population from the subventricular region of the adult mouse forebrain. J. Neurosci. 19, 3287-3297.
50. Gritti A., Bonfanti L., Doetsch F., Caille I., Alvarez-Buylla A., Lim D.A., Galli R., Verdugo J.M., Herrera D.G. and Vescovi A.L. (2002). Multipotent neural stem cells reside into the rostral extension and olfactory bulb of adult rodents. J. Neurosci. 22, 437-445.
51. Gritti A., Parati E.A., Cova L., Frolichsthal P., Galli R., Wanke E., Faravelli L., Morassutti D.J., Roisen F., Nickel D.D. and Vescovi A.L. (1996). Multipotential stem cells from the adult mouse brain proliferate and self-renew in response to basic fibroblast growth factor. J. Neurosci. 16, 1091-1100.
52. Haskins M.E., Giger U. and Patterson D.F. (2006). Animal models of lysosomal storage diseases: Their development and clinical relevance. In: Fabri disease: Perspectives from 5 years of FOS. Chapter 6. Mehtra A., Beck M. and Sunder-Plassmann G. (eds). Oxford Pharmagenesis. Oxford
53. Hedlund E., Hefferan M.P., Marsala M. and Isacson O. (2007). Cell therapy and stem cells in animal models of motor neuron disorders. Eur. J. Neurosci. 26, 1721-1737.
54. Hensley K., Floyd R.A., Gordon B., Mou S., Pye Q.N., Stewart C., West M. and Williamson K. (2002). Temporal patterns of cytokine and apoptosis-related gene expression in spinal cords of the g93a-sod1 mouse model of amyotrophic lateral sclerosis. J. Neurochem. 82, 365-374.
55. Hess B., Saftig P., Hartmann D., Coenen R., Lullmann-Rauch R., Goebel H.H., Evers M., von Figura K., D'Hooge R., Nagels G., De Deyn P., Peters C. and Gieselmann V. (1996). Phenotype of arylsulfatase a-deficient mice: Relationship to human metachromatic leukodystrophy. Proc. Natl. Acad. Sci. USA 93, 14821-14826.
56. Imitola J., Comabella M., Chandraker A.K., Dangond F., Sayegh M.H., Snyder E.Y. and Khoury S.J. (2004a). Neural stem/progenitor cells express costimulatory molecules that are differentially regulated by inflammatory and apoptotic stimuli. Am. J. Pathol. 164, 1615-1625.
57. Imitola J., Raddassi K., Park K.I., Mueller F.J., Nieto M., Teng Y.D., Frenkel D., Li J., Sidman R.L., Walsh C.A., Snyder E.Y. and Khoury S.J. (2004b). Directed migration of neural stem cells to sites of CNS injury by the stromal cell-derived factor 1alpha/cxc chemokine receptor 4 pathway. Proc. Natl. Acad. Sci. USA 101, 18117-18122.
58. Jandial R., Singec I., Ames C.P. and Snyder E.Y. (2008). Genetic modification of neural stem cells. Mol. Ther. 16, 450-457.
59. Janson C.G., McPhee S.W., Francis J., Shera D., Assadi M., Freese A., Hurh P., Haselgrove J., Wang D.J., Bilaniuk L. and Leone P. (2006). Natural history of canavan disease revealed by proton magnetic resonance spectroscopy (1h-mrs) and diffusion-weighted MRI. Neuropediatrics 37, 209-221.
60. Jeyakumar M., Thomas R., Elliot-Smith E., Smith D.A., van der Spoel A.C., d'Azzo A., Perry V.H., Butters T.D., Dwek R.A. and Platt F.M. (2003). Central nervous system inflammation is a hallmark of pathogenesis in mouse models of GM1 and GM2 gangliosidosis. Brain 126, 974-987.
61. Jordan P.M., Ojeda L.D., Thonhoff J.R., Gao J., Boehning D., Yu Y. and Wu P. (2009). Generation of spinal motor neurons from human fetal brain-derived neural stem cells: Role of basic fibroblast growth factor. J. Neurosci. Res. 87, 318-332.
62. Kakkis E.D., Muenzer J., Tiller G.E., Waber L., Belmont J., Passage M., Izykowski B., Phillips J., Doroshow R., Walot I., Hoft R. and Neufeld E.F. (2001). Enzyme-replacement therapy in mucopolysaccharidosis I. N. Engl. J. Med. 344, 182-188.
63. Kaspar B.K., Llado J., Sherkat N., Rothstein J.D. and Gage F.H. (2003). Retrograde viral delivery of igf-1 prolongs survival in a mouse als model. Science 301, 839-842.
64. Kelly S., Bliss T.M., Shah A.K., Sun G.H., Ma M., Foo W.C., Masel J., Yenari M.A., Weissman I.L., Uchida N., Palmer T. and Steinberg G.K. (2004). Transplanted human fetal neural stem cells survive, migrate, and differentiate in ischemic rat cerebral cortex. Proc. Natl. Acad. Sci. USA 101, 11839-11844.
65. Kohn D.B., Sadelain M. and Glorioso J.C. (2003). Occurrence of leukaemia following gene therapy of x-linked scid. Nat. Rev. Cancer 3, 477-488.
66. Kondo Y., Wenger D.A., Gallo V. and Duncan I.D. (2005). Galactocerebrosidase-deficient oligodendrocytes maintain stable central myelin by exogenous replacement of the missing enzyme in mice. Proc. Natl. Acad. Sci. USA 102, 18670-18675.
67. Kornfeld S. and Mellman I. (1989). The biogenesis of lysosomes. Annu. Rev. Cell Biol. 5, 483-525.
68. Kosuga M., Sasaki K., Tanabe A., Li X.K., Okawa H., Ogino I., Okuda O., Arai H., Sakuragawa N., Kamata Y., Azuma N., Suzuki S., Yamada M. and Okuyama T. (2001). Engraftment of genetically engineered amniotic epithelial cells corrects lysosomal storage in multiple areas of the brain in mucopolysaccharidosis type vii mice. Mol. Ther. 3, 139-148.
69. Kuhn H.G., Winkler J., Kempermann G., Thal L.J. and Gage F.H. (1997). Epidermal growth factor and fibroblast growth factor-2 have different effects on neural progenitors in the adult rat brain. J. Neurosci. 17, 5820-5829.
70. Kusano K., Enomoto M., Hirai T., Tsoulfas P., Sotome S., Shinomiya K. and Okawa A. (2010). Transplanted neural progenitor cells expressing mutant nt3 promote myelination and partial hindlimb recovery in the chronic phase after spinal cord injury. Biochem. Biophys. Res. Commun. 393, 812-817.
71. Lee J.P., Jeyakumar M., Gonzalez R., Takahashi H., Lee P.J., Baek R.C., Clark D., Rose H., Fu G., Clarke J., McKercher S., Meerloo J., Muller F. J., Park K. I., Butters T.D., Dwek R.A., Schwartz P., Tong G., Wenger D., Lipton S.A., Seyfried T.N., Platt F.M. and Snyder E.Y. (2007). Stem cells act through multiple mechanisms to benefit mice with neurodegenerative metabolic disease. Nat. Med. 13, 439-447.
72. Leigh P.N. and Ray-Chaudhuri K. (1994). Motor neuron disease. J. Neurol. Neurosurg. Psychiatry 57, 886-896.
73. Li X.J., Du Z.W., Zarnowska E.D., Pankratz M., Hansen L.O., Pearce R.A. and Zhang S.C. (2005). Specification of motoneurons from human embryonic stem cells. Nat. Biotechnol. 23, 215-221.
74. Li X.J., Hu B.Y., Jones S.A., Zhang Y.S., Lavaute T., Du Z.W. and Zhang S.C. (2008). Directed differentiation of ventral spinal progenitors and motor neurons from human embryonic stem cells by small molecules. Stem Cells 26, 886-893.
75. Lichtenwalner R.J. and Parent J.M. (2006). Adult neurogenesis and the ischemic forebrain. J. Cereb. Blood Flow Metab. 26, 1-20.
76. Lindvall O. and Bjorklund A. (2004). Cell replacement therapy: Helping the brain to repair itself. NeuroRx 1, 379-381.
77. Lindvall O., Kokaia Z. and Martinez-Serrano A. (2004). Stem cell therapy for human neurodegenerative disorders-how to make it work. Nat. Med. 10 (Suppl), S42-50.
78. Logroscino G., Traynor B.J., Hardiman O., Chio A., Mitchell D., Swingler R. J., Millul A., Benn E. and Beghi E. (2010). Incidence of amyotrophic lateral sclerosis in europe. J. Neurol. Neurosurg. Psychiatry 81, 385-390.
79. Lomen-Hoerth C., Murphy J., Langmore S., Kramer J.H., Olney R.K. and Miller B. (2003). Are amyotrophic lateral sclerosis patients cognitively normal? Neurology 60, 1094-1097.
80. Ma D.K., Marchetto M.C., Guo J.U., Ming G.L., Gage F.H. and Song H. (2010). Epigenetic choreographers of neurogenesis in the adult mammalian brain. Nat. Neurosci. 13, 1338-1344.
81. Martin L.J. and Liu Z. (2007). Adult olfactory bulb neural precursor cell grafts provide temporary protection from motor neuron degeneration, improve motor function, and extend survival in amyotrophic lateral sclerosis mice. J. Neuropathol. Exp. Neurol. 66, 1002-1018.
82. Martinez-Serrano A., Fischer W. and Bjorklund A. (1995a). Reversal of age-dependent cognitive impairments and cholinergic neuron atrophy by ngf-secreting neural progenitors grafted to the basal forebrain. Neuron 15, 473-484.
83. Martinez-Serrano A., Lundberg C., Horellou P., Fischer W., Bentlage C., Campbell K., McKay R.D., Mallet J. and Bjorklund A. (1995b). Cnsderived neural progenitor cells for gene transfer of nerve growth factor to the adult rat brain: Complete rescue of axotomized cholinergic neurons after transplantation into the septum. J. Neurosci. 15, 5668-5680.
84. Martino S., di Girolamo I., Cavazzin C., Tiribuzi R., Galli R., Rivaroli A., Valsecchi M., Sandhoff K., Sonnino S., Vescovi A., Gritti A. and Orlacchio A. (2009). Neural precursor cell cultures from gm2 gangliosidosis animal models recapitulate the biochemical and molecular hallmarks of the brain pathology. J. Neurochem. 109, 135-147.
85. Mazzini L., Mareschi K., Ferrero I., Vassallo E., Oliveri G., Nasuelli N., Oggioni G. D., Testa L. and Fagioli F. (2008). Stem cell treatment in amyotrophic lateral sclerosis. J. Neurol. Sci. 265, 78-83.
86. McGlynn R., Dobrenis K. and Walkley S.U. (2004). Differential subcellular localization of cholesterol, gangliosides, and glycosaminoglycans in murine models of mucopolysaccharide storage disorders. J. Comp. Neurol. 480, 415-426.
87. Mehta A., Beck M., Eyskens F., Feliciani C., Kantola I., Ramaswami U., Rolfs A., Rivera A., Waldek S. and Germain D.P. (2010). Fabry disease: A review of current management strategies. QJM 103, 641-659.
88. Meikle P.J., Hopwood J.J., Clague A. E. and Carey W.F. (1999). Prevalence of lysosomal storage disorders. JAMA 281, 249-254.
89. Mendez I., Vinuela A., Astradsson A., Mukhida K., Hallett P., Robertson H., Tierney T., Holness R., Dagher A., Trojanowski J.Q. and Isacson O. (2008). Dopamine neurons implanted into people with parkinson's disease survive without pathology for 14 years. Nat. Med. 14, 507-509.
90. Meng X.L., Shen J.S., Ohashi T., Maeda H., Kim S.U. and Eto Y. (2003). Brain transplantation of genetically engineered human neural stem cells globally corrects brain lesions in the mucopolysaccharidosis type vii mouse. J. Neurosci. Res. 74, 266-277.
91. Muenzer J., Gucsavas-Calikoglu M., McCandless S.E., Schuetz T.J. and Kimura A. (2007). A phase i/ii clinical trial of enzyme replacement therapy in mucopolysaccharidosis ii (hunter syndrome). Mol. Genet. Metab. 90, 329-337.
92. Muenzer J., Lamsa J.C., Garcia A., Dacosta J., Garcia J. and Treco D.A. (2002). Enzyme replacement therapy in mucopolysaccharidosis type ii (hunter syndrome): A preliminary report. Acta Paediatr. Suppl. 91, 98-99.
93. Muenzer J., Wraith J.E., Beck M., Giugliani R., Harmatz P., Eng C.M., Vellodi A., Martin R., Ramaswami U., Gucsavas-Calikoglu M., Vijayaraghavan S., Wendt S., Puga A.C., Ulbrich B., Shinawi M., Cleary M., Piper D., Conway A.M. and Kimura A. (2006). A phase ii/iii clinical study of enzyme replacement therapy with idursulfase in mucopolysaccharidosis ii (hunter syndrome). Genet. Med. 8, 465-473.
94. Myerowitz R., Lawson D., Mizukami H., Mi Y., Tifft C.J. and Proia R.L. (2002). Molecular pathophysiology in tay-sachs and sandhoff diseases as revealed by gene expression profiling. Human Mol. Genet. 11, 1343-1350.
95. Nakatomi H., Kuriu T., Okabe S., Yamamoto S., Hatano O., Kawahara N., Tamura A., Kirino T. and Nakafuku M. (2002). Regeneration of hippocampal pyramidal neurons after ischemic brain injury by recruitment of endogenous neural progenitors. Cell 110, 429-441.
96. Nayak M.S., Kim Y.S., Goldman M., Keirstead H.S. and Kerr D.A. (2006). Cellular therapies in motor neuron diseases. Biochim. Biophys. Acta 1762, 1128-1138.
97. Neri M., Maderna C., Ferrari D., Cavazzin C., Vescovi A.L. and Gritti A. (2010). Robust generation of oligodendrocyte progenitors from human neural stem cells and engraftment in experimental demyelination models in mice. PLoS One 5, e10145.
98. Nizzardo M., Simone C., Falcone M., Locatelli F., Riboldi G., Comi G.P. and Corti S. (2010). Human motor neuron generation from embryonic stem cells and induced pluripotent stem cells. Cell Mol. Life Sci. 67, 3837-3847.
99. Norris F., Shepherd R., Denys E., Mukai E., Elias L., Holden D. and Norris H. (1993). Onset, natural history and outcome in idiopathic adult motor neuron disease. J. Neurol. Sci. 118, 48-55.
100. Norris F.H. Jr., Aguilar M.J., Colton R.P., Oldstone M.B. and Cremer N.E. (1975). Tubular particles in a case of recurrent lymphocytic meningitis followed by amyotrophic lateral sclerosis. J. Neuropathol. Exp. Neurol. 34, 133-147.
101. Okita K., Nakagawa M., Hyenjong H., Ichisaka T. and Yamanaka S. (2008). Generation of mouse induced pluripotent stem cells without viral vectors. Science 322, 949-953.
102. Olstorn H., Moe M.C., Roste G.K., Bueters T. and Langmoen I.A. (2007). Transplantation of stem cells from the adult human brain to the adult rat brain. Neurosurgery 60, 1089-1098.
103. Pan D. (2011). Cell-and gene-based therapeutic approaches for neurological deficits in mucopolysaccharidoses. Curr. Pharm. Biotechnol. 12, 884-896.
104. Park K.I., Teng Y.D. and Snyder E.Y. (2002). The injured brain interacts reciprocally with neural stem cells supported by scaffolds to reconstitute lost tissue. Nat. Biotechnol. 20, 1111-1117.
105. Park K.I., Himes B.T., Stieg P.E., Tessler A., Fischer I. and Snyder E.Y. (2006). Neural stem cells may be uniquely suited for combined gene therapy and cell replacement: Evidence from engraftment of neurotrophin-3-expressing stem cells in hypoxic-ischemic brain injury. Exp. Neurol. 199, 179-190.
106. Park K.I., Ourednik J., Ourednik V., Taylor R.M., Aboody K.S., Auguste K.I., Lachyankar M.B., Redmond D.E. and Snyder E.Y. (2002). Global gene and cell replacement strategies via stem cells. Gene Ther. 9, 613-624.
107. Pluchino S., Gritti A., Blezer E., Amadio S., Brambilla E., Borsellino G., Cossetti C., Del Carro U., Comi G.,Hart B., Vescovi A. and Martino G. (2009). Human neural stem cells ameliorate autoimmune encephalomyelitis in non-human primates. Ann. Neurol. 66, 343-354.
108. Pluchino S., Zanotti L., Rossi B., Brambilla E., Ottoboni L., Salani G., Martinello M., Cattalini A., Bergami A., Furlan R., Comi G., Constantin G. and Martino G. (2005). Neurosphere-derived multipotent precursors promote neuroprotection by an immunomodulatory mechanism. Nature 436, 266-271.
109. Pluchino S., Quattrini A., Brambilla E., Gritti A., Salani G., Dina G., Galli R., Del Carro U., Amadio S., Bergami A., Furlan R., Comi G., Vescovi A.L. and Martino G. (2003). Injection of adult neurospheres induces recovery in a chronic model of multiple sclerosis. Nature 422, 688-694.
110. Raore B., Federici T., Taub J., Wu M.C., Riley J., Franz C.K., Kliem M.A., Snyder B., Feldman E.L., Johe K. and Boulis N.M. (2011). Cervical multilevel intraspinal stem cell therapy: Assessment of surgical risks in gottingen minipigs. Spine (Phila Pa 1976) 36, E164-171.
111. Raper S.E., Chirmule N., Lee F.S., Wivel N.A., Bagg A., Gao G.P., Wilson J.M. and Batshaw M.L. (2003). Fatal systemic inflammatory response syndrome in a ornithine transcarbamylase deficient patient following adenoviral gene transfer Mol. Genet. Metab. 80, 148-158.
112. Reynolds B.A. and Weiss S. (1992). Generation of neurons and astrocytes from isolated cells of the adult mammalian central nervous system. Science 255, 1707-1710.
113. Ringholz G.M., Appel S.H., Bradshaw M., Cooke N.A., Mosnik D.M. and Schulz P. E. (2005). Prevalence and patterns of cognitive impairment in sporadic ALS. Neurology 65, 586-590.
114. Rossi D., Brambilla L., Valori C.F., Roncoroni C., Crugnola A., Yokota T., Bredesen D.E. and Volterra A. (2008). Focal degeneration of astrocytes in amyotrophic lateral sclerosis. Cell Death Differ. 15, 1691-1700.
115. Rota Nodari L., Ferrari D., Giani F., Bossi M., Rodriguez-Menendez V., Tredici G., Delia D., Vescovi A.L. and De Filippis L. (2010). Longterm survival of human neural stem cells in the ischemic rat brain upon transient immunosuppression. PLoS One 5, e14035.
116. Rowland L.P. and Shneider N.A. (2001). Amyotrophic lateral sclerosis. N. Engl. J. Med. 344, 1688-1700.
117. Sargsyan S.A., Monk P.N. and Shaw P.J. (2005). Microglia as potential contributors to motor neuron injury in amyotrophic lateral sclerosis. Glia 51, 241-253.
118. Sathasivam S. (2010). Motor neurone disease: Clinical features, diagnosis, diagnostic pitfalls and prognostic markers. Singapore Med. J. 51, 367-372; quiz 373.
119. Simpson E.P., Henry Y.K., Henkel J.S., Smith R.G. and Appel S. H. (2004). Increased lipid peroxidation in sera of ALS patients: A potential biomarker of disease burden. Neurology 62, 1758-1765.
120. Singh Roy N., Nakano T., Xuing L., Kang J., Nedergaard M. and Goldman S.A. (2005). Enhancer-specified gfp-based facs purification of human spinal motor neurons from embryonic stem cells. Exp. Neurol. 196, 224-234.
121. Sly W.S. and Vogler C. (2002). Brain-directed gene therapy for lysosomal storage disease: Going well beyond the blood-brain barrier. Proc. Natl. Acad. Sci. USA 99, 5760-5762.
122. Snyder E.Y., Taylor R.M. and Wolfe J.H. (1995). Neural progenitor cell engraftment corrects lysosomal storage throughout the mps vii mouse brain. Nature 374, 367-370.
123. Storkebaum E., Lambrechts D., Dewerchin M., Moreno-Murciano M.P., Appelmans S., Oh H., Van Damme P., Rutten B., Man W.Y., De Mol M., Wyns S., Manka D., Vermeulen K., Van Den Bosch L., Mertens N., Schmitz C., Robberecht W., Conway E.M., Collen D., Moons L. and Carmeliet P. (2005). Treatment of motoneuron degeneration by intracerebroventricular delivery of vegf in a rat model of ALS. Nat. Neurosci. 8, 85-92.
124. Stroemer P., Hope A., Patel S., Pollock K. and Sinden J. (2008). Development of a human neural stem cell line for use in recovery from disability after stroke. Front. Biosci. 13, 2290-2292.
125. Stroemer P., Patel S., Hope A., Oliveira C., Pollock K. and Sinden J. (2009). The neural stem cell line ctx0e03 promotes behavioral recovery and endogenous neurogenesis after experimental stroke in a dose-dependent fashion. Neurorehabil. Neural Repair 23, 895-909.
126. Suzuki M. and Svendsen C.N. (2008). Combining growth factor and stem cell therapy for amyotrophic lateral sclerosis. Trends Neurosci. 31, 192-198.
127. Suzuki M., McHugh J., Tork C., Shelley B., Klein S.M., Aebischer P. and Svendsen C.N. (2007). GDNF secreting human neural progenitor cells protect dying motor neurons, but not their projection to muscle, in a rat model of familial als. PLoS One 2, e689.
128. Tartaglia M.C., Rowe A., Findlater K., Orange J.B., Grace G. and Strong M.J. (2007). Differentiation between primary lateral sclerosis and amyotrophic lateral sclerosis: Examination of symptoms and signs at disease onset and during follow-up. Arch. Neurol. 64, 232-236.
129. Taupin P. (2006a). Adult neural stem cells, neurogenic niches, and cellular therapy. Stem Cell Rev 2, 213-219.
130. Taupin P. (2006b). Therapeutic potential of adult neural stem cells. Recent Pat. CNS Drug Discov. 1, 299-303.
131. Taupin P. (2006c). HuCNS-SC (stemcells). Current Opin. Mol. Therapeutic. 8, 156-163.
132. Taylor R.M. and Wolfe J.H. (1997). Decreased lysosomal storage in the adult MPS VII mouse brain in the vicinity of grafts of retroviral vectorcorrected fibroblasts secreting high levels of beta-glucuronidase. Nat. Med. 3, 771-774.
133. Thonhoff J.R., Ojeda L. and Wu P. (2009). Stem cell-derived motor neurons: Applications and challenges in amyotrophic lateral sclerosis. Curr. Stem Cell Res. Ther. 4, 178-199.
134. Thonhoff J.R., Jordan P.M., Karam J.R., Bassett B.L. and Wu P. (2007). Identification of early disease progression in an als rat model. Neurosci. Lett. 415, 264-268.
135. Trujillo C.A., Schwindt T.T., Martins A.H., Alves J.M., Mello L.E. and Ulrich H. (2009). Novel perspectives of neural stem cell differentiation: From neurotransmitters to therapeutics. Cytometry A 75, 38-53.
136. Van den Hout H., Reuser A.J., Vulto A.G., Loonen M.C., Cromme-Dijkhuis A. and Van der Ploeg A.T. (2000). Recombinant human alpha-glucosidase from rabbit milk in pompe patients. Lancet 356, 397-398.
137. Vescovi A. L., Parati E. A., Gritti A., Poulin P., Ferrario M., Wanke E., Frolichsthal-Schoeller P., Cova L., Arcellana-Panlilio M., Colombo A. and Galli R. (1999). Isolation and cloning of multipotential stem cells from the embryonic human cns and establishment of transplantable human neural stem cell lines by epigenetic stimulation. Exp. Neurol. 156, 71-83.
138. Villa A., Snyder E.Y., Vescovi A. and Martinez-Serrano A. (2000). Establishment and properties of a growth factor-dependent, perpetual neural stem cell line from the human CNS. Exp. Neurol. 161, 67-84.
139. Visser J., de Jong J.M. and de Visser M. (2008). The history of progressive muscular atrophy: Syndrome or disease? Neurology 70, 723-727.
140. Wada R., Tifft C.J. and Proia R.L. (2000). Microglial activation precedes acute neurodegeneration in sandhoff disease and is suppressed by bone marrow transplantation. Proc. Natl. Acad. Sci. USA 97, 10954-10959.
141. Weiss S., Dunne C., Hewson J., Wohl C., Wheatley M., Peterson A.C. and Reynolds B.A. (1996). Multipotent cns stem cells are present in the adult mammalian spinal cord and ventricular neuroaxis. J. Neurosci. 16, 7599-7609.
142. Wennersten A., Holmin S., Al Nimer F., Meijer X., Wahlberg L.U. and Mathiesen T. (2006). Sustained survival of xenografted human neural stem/progenitor cells in experimental brain trauma despite discontinuation of immunosuppression. Exp. Neurol. 199, 339-347.
143. Weydt P. and Moller T. (2005). The role of microglial cells in amyotrophic lateral sclerosis. Phys. Med. Rehabil. Clin. N. Am. 16, 1081-1090, xi.
144. Wraith J.E. (2002). Lysosomal disorders. Semin. Neonatol. 7, 75-83.
145. Wraith J.E. (2008). Enzyme replacement therapy with idursulfase in patients with mucopolysaccharidosis type II. Acta Paediatr. Suppl. 97, 76-78.
146. Wu P., Tarasenko Y.I., Gu Y., Huang L.Y., Coggeshall R.E. and Yu Y. (2002). Region-specific generation of cholinergic neurons from fetal human neural stem cells grafted in adult rat. Nat. Neurosci. 5, 1271-1278.
147. Xiao Q., Zhao W., Beers D.R., Yen A.A., Xie W., Henkel J.S. and Appel S.H. (2007). Mutant sod1(g93a) microglia are more neurotoxic relative to wild-type microglia. J. Neurochem. 102, 2008-2019.
148. Xie Y., Weydt P., Howland D.S., Kliot M. and Moller T. (2004). Inflammatory mediators and growth factors in the spinal cord of G93A SOD1 rats. Neuroreport 15, 2513-2516.
149. Xuan A.G., Luo M., Ji W.D. and Long D.H. (2009). Effects of engrafted neural stem cells in alzheimer's disease rats. Neurosci. Lett. 450, 167-171.
150. Yan J., Xu L., Welsh A.M., Chen D., Hazel T., Johe K. and Koliatsos V.E. (2006). Combined immunosuppressive agents or cd4 antibodies prolong survival of human neural stem cell grafts and improve disease outcomes in amyotrophic lateral sclerosis transgenic mice. Stem Cells 24, 1976-1985.
151. Yang J., Jiang Z., Fitzgerald D.C., Ma C., Yu S., Li H., Zhao Z., Li Y., Ciric B., Curtis M., Rostami A. and Zhang G.X. (2009). Adult neural stem cells expressing il-10 confer potent immunomodulation and remyelination in experimental autoimmune encephalitis. J. Clin. Invest. 119, 3678-3691.
152. Yang S.Y., Liu H. and Zhang J.N. (2004). Gene therapy of rat malignant gliomas using neural stem cells expressing il-12. DNA Cell. Biol. 23, 381-389.
153. Zheng C., Nennesmo I., Fadeel B. and Henter J.I. (2004). Vascular endothelial growth factor prolongs survival in a transgenic mouse model of ALS. Ann. Neurol. 56, 564-567.